Document is current
Any future updates will be listed below
-
Authors
Hannuksela, Noora https://orcid.org/0009-0000-0894-6333
Partanen, Anu
Anttalainen, Anna
Ukkola-Vuoti, Liisa
Toppila, Iiro
Vikkula, Johanna https://orcid.org/0000-0002-5750-6120
Marin, Katja
Kuitunen, Hanne
Miettinen, Tatu
Kuittinen, Outi
Rönkä, Aino
-
Funding
Funding for this research was provided by:
The
- License Information
-
More Information
Article History
Received: 7 May 2024
Revised: 11 August 2024
Accepted: 12 August 2024
First Online: 20 August 2024
Competing interests
: AR reports personal fees for speaking at symposia or financial support for attending conferences from Amgen, Bristol-Myers Squibb, Merck, Novartis, Pfizer, Daichii Sankyo and Roche. AP reports honoraria from Behring and Abbvie and has participated in Scientific Advisory Board meetings organized by Abbvie, Janssen-Cilag, Novartis, Pfizer and Takeda. None of the financial support was related to the present study. TM has been contractor by Takeda Oy during the study time. LU-V, IT, JV, and AA are employed by Medaffcon Oy. The rest of the authors declared no competing interests.
